SingletO2 Therapeutics
New Providence
About SingletO2 Therapeutics
SingletO2 Therapeutics creates new treatments for periodontal disease using singlet oxygen. The company was founded in 2015 and is headquartered in New Providence, New Jersey.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $431.0K
- Last round: Grant (Oct 2024)
- Website: singleto2.com
Industries & Categories
Biotechnology, Health Care, Therapeutics
Canonical: https://fsome.com/organization/singleto2-therapeutics-189147 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.